Keith McCormick

Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: Results from the WELCOME* study

Eleonora Scorletti, Lokpal Bhatia, Keith McCormick et al. · Hepatology · 2014 · 310 citations

Medicine, Nutritional Sciences, Pharmacology +17

Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trial

Eleonora Scorletti, Annette L. West, Lokpal Bhatia et al. · Journal of Hepatology · 2015 · 109 citations

Life Sciences, Biochemistry, Molecular Medicine +13

Better maintained adherence on switching from twice‐daily to once‐daily therapy for HIV: a 24‐week randomized trial of treatment simplification using stavudine prolonged‐release capsules

SD Portsmouth, Keith McCormick, BG Gazzard et al. · HIV Medicine · 2005 · 67 citations

Pharmacy, Clinical Pharmacy, Pharmacotherapy +16

Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chain omega-3 fatty treatment in non-alcoholic fatty liver disease

Eleonora Scorletti, Lokpal Bhatia, Keith McCormick et al. · Contemporary Clinical Trials · 2014 · 44 citations

Medicine, Pharmacology, Pharmacotherapy +7

Impact of high dose n-3 polyunsaturated fatty acid treatment on measures of microvascular function and vibration perception in non-alcoholic fatty liver disease: results from the randomised WELCOME trial

Keith McCormick, Eleonora Scorletti, Lokpal Bhatia et al. · Diabetologia · 2015 · 19 citations · Full text

Agriculture, Nutrition, Nutritional Sciences +15